N-[(4s,8e,11s)-4-[(1r)-1-hydroxy-2-{[3-(propan-2-yl)benzyl]amino}ethyl]-2,13-dioxo-11-phenyl-6-oxa-3,12-diazabicyclo[12.3.1]octadeca-1(18),8,14,16-tetraen-16-yl]-n-methylmethanesulfonamide (0LG) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.14
Number of clusters 34
Number of clusters representing 95% 10
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 0.9617
ΔGstrain (kcal/mol) 0
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 1971 0 1.6795
2 1569 0.1350 3.1351
3 1451 0.1813 1.7234
4 1222 0.2830 3.7349
5 1013 0.3941 1.935
6 610 0.6945 2.5007
7 526 0.7822 3.5109
8 520 0.7890 3.9119
9 331 1.0565 2.8984
10 259 1.2018 2.6052
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)